Tirtha Chakraborty
Chief Tech/Sci/R&D Officer at VOR BIOPHARMA INC.
Net worth: 304 696 $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Samarth Kulkarni | M | 45 | 9 years | |
Bill Lundberg | M | 60 | 9 years | |
Matt Patterson | M | 52 | 4 years | |
Richard Mulligan | M | 69 | 6 years | |
Bob Ang | M | 49 | 5 years | |
Jim Kasinger | M | 52 | 7 years | |
Steven Kanner | M | 65 |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | 1 years |
Sarah Spencer | F | - | - | |
Patrick Yang | M | 75 | 6 years | |
Daniella Beckman | F | 45 | 4 years | |
Joshua Resnick | M | 49 | 5 years | |
Jonathan Terrett | M | - | 7 years | |
Ali Behbahani | M | 47 | 9 years | |
Simeon George | M | 46 | 9 years | |
Brent Stead | M | - |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
David Lubner | M | 60 | 4 years | |
Eyal Attar | M | 53 | 2 years | |
Tania Philipp | F | 52 | 5 years | |
Odisho Israel | M | - |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
Shanna Peek | F | - | 5 years | |
Sonja Schrepfer | M | 49 | 5 years | |
Christian Hordo | M | 41 | 6 years | |
Michael Nicholson | M | 57 |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | 1 years |
Nikhil Thatte | M | - |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
Michael Mee | M | - | 5 years | |
John C. King | M | 49 | 4 years | |
Megan Wherry Menner | F | - | 8 years | |
Nathan Jorgensen | M | 47 | 4 years | |
Robert G. Pietrusko | M | 76 | 4 years | |
Daniel Hetu | M | - |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
Frederic Auger | M | - |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kush Parmar | M | 42 | 4 years | |
Pablo Cagnoni | M | 60 | 4 years | |
Lawrence Klein | M | 41 | - | |
Michael Tomsicek | M | 58 | 4 years | |
Kala Subramanian | M | 57 | - | |
Geoffrey von Maltzahn | M | 43 | 2 years | |
Kurt von Emster | M | 56 | 4 years | |
James Sullivan | M | 45 | 2 years | |
N. Coles | M | 63 | 2 years | |
Marc A. Becker | M | 52 | 1 years | |
Chris Erdman | M | - | 1 years | |
Michael Bruce | M | - | 2 years | |
Tyle M. Dylan-Hyde | M | 62 | 3 years | |
Michael Esposito | M | 59 | - | |
Tony Ho | M | 58 | 4 years | |
Steven Caffé | M | - | 5 years | |
Sadik Kassim | M | - | 2 years | |
Richard Schwartz | M | - | 1 years | |
Stephen Sofen | M | - | 2 years | |
Stacey Ma | M | 54 | - | |
Christopher Slapak | M | 65 | 3 years | |
Amy Mendel | F | 44 | 3 years | |
Shelby Walker | F | - | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 25 | 46.30% |
Switzerland | 23 | 42.59% |
Canada | 7 | 12.96% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tirtha Chakraborty
- Personal Network